featured
Use of 0.25% Loteprednol Etabonate Ophthalmic Suspension for Dry Eye Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Ophthalmology (Auckland, N.Z.)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Practical Guidance for the Use of Loteprednol Etabonate Ophthalmic Suspension 0.25% in the Management of Dry Eye Disease
Clin Ophthalmol 2022 Feb 01;16(16)349-355, N Venkateswaran, Y Bian, PK GuptaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.